Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-25

FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for Amitriptyline hydrochloride by Sandoz Inc, indicating approval of changes to the existing generic labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amitriptyline hydrochloride (amitriptyline hydrochloride)

Snippet

SUPPL AP for AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE)